Cargando…
CA916798 gene expression is associated with multidrug resistance and predicts progression-free survival in patients with lung cancer
CA916798 has been identified as a novel multidrug resistance gene in lung cancer cells. However, the expression patterns of CA916798 in tumor tissues prior and subsequent to chemotherapy remain unclear. In the present study, CA916798 expression levels in tumor tissues prior and subsequent to chemoth...
Autores principales: | Duan, Hailing, Yang, Zaixing, Liang, Lan, Zhou, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607038/ https://www.ncbi.nlm.nih.gov/pubmed/31423177 http://dx.doi.org/10.3892/ol.2019.10436 |
Ejemplares similares
-
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
por: He, Jian, et al.
Publicado: (2023) -
Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798
por: Yang, Xuemei, et al.
Publicado: (2017) -
Akt1 Enhances CA916798 Expression through mTOR Pathway
por: Wang, Yu-Liang, et al.
Publicado: (2013) -
ABCC3 as a marker for multidrug resistance in non-small cell lung cancer
por: Zhao, Yanbin, et al.
Publicado: (2013) -
Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2020)